| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 1,732 | 2,576 | 8,616 | | Cost of Revenue | 992 | 3,369 | 10,201 | | | Gross Profit | 740 | (793) | (1,585) | | | Operating Expenses | | Research Development | 9,048 | 9,924 | 9,002 | | Selling General and Administrative | 11,231 | 8,092 | 8,664 | | Non Recurring | 131 |
-
| 646 | | Others | 191 | 191 | 191 | | | | Total Operating Expenses | 20,601 |
-
| 18,504 | | | | Operating Income or Loss | (19,861) | (19,001) | (20,089) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,796) | 922 | 4 | | Earnings Before Interest And Taxes | (23,658) | (18,078) | (20,085) | | Interest Expense | 1,659 | 485 |
-
| | Income Before Tax | (25,317) | (18,564) | (20,085) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (25,317) | (18,564) | (20,085) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (25,317) | (18,564) | (20,085) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($25,317) | ($18,564) | ($20,085) |
|
1.48% Nasdaq 0.00%
Income Statement
